GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Hgf | multiple interactions | EXP | | 6480464 | CTD | 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of HGF mRNA]; 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of HGF protein]; [Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of HGF mRNA; [Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of HGF protein | PMID:28844859 | Hgf | increases expression | ISO | Hgf (Mus musculus) | 6480464 | CTD | Lipopolysaccharides results in increased expression of HGF mRNA | PMID:12057914 | Hgf | increases expression | ISO | HGF (Homo sapiens) | 6480464 | CTD | Lipopolysaccharides results in increased expression of HGF mRNA | PMID:35953652 | Hgf | multiple interactions | ISO | HGF (Homo sapiens) | 6480464 | CTD | [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of HGF mRNA; Lipopolysaccharides inhibits the reaction [Sevoflurane results in increased expression of HGF mRNA]; Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of HGF mRNA] | PMID:35811015 PMID:35953652 | |
Go Back to source page | Continue to Ontology report |